AliveX Biotech Named Among BIOHK2024's 'Top 5 to Watch' Companies and Files IPO Prospectus
AliveX Biotech
Precision Medicine Solution Provider
From September 11 to 14, 2024, BIOHK2024 Hong Kong International Biotechnology Forum and Exhibition was grandly held at the Hong Kong International Convention and Exhibition Center. As an authoritative event in the industry, BIOHK2024 promotes the high-quality development of China's biotechnology industry with an international perspective and serves as an important platform for showcasing new products, technologies, services, and collaboration opportunities.
This grand event brought together more than 200 industry leaders and experts, featuring over 120 booths on-site and attracting registration from 2,600 professional visitors to exchange and discuss the latest research achievements and industry trends.
BIOHK, as a globally leading biotechnology event, brings together numerous industry leaders and emerging companies.AliveX Biotech Shines at BIOHK2024 Innovation Enterprise Roadshow, Winning "Top 5 Most Noteworthy Companies" AwardThis honor is a high recognition of our company's innovative strength, forward-looking R&D capabilities, and outstanding achievements in the industry.
This award not only demonstrates AliveX Biotech's core competitiveness in the biotechnology field but also further enhances our influence on the international stage. In the future, we will continue to uphold the concept of innovation-driven development, committing ourselves to promoting the application and advancement of biotechnology, and creating more value for the industry!
About AliveX Biotech
AliveX Biotech is a leading AI + multi-omics technology platform company in China, with an end-to-end dry and wet lab closed-loop multi-omics experimental platform and an AI biocomputing platform. These include high-quality bioanalytical technologies such as spatiotemporal single-cell omics, targeted proteomics, metabolomics/lipidomics, and computational technologies like multi-omics integrative analysis, AI modeling, knowledge graphs, and disease pharmacological mechanism modeling to efficiently empower R&D. AliveX Biotech boasts an internationally leading interdisciplinary team of academician professors and industry experts, providing customized research solutions for scientific research and pharmaceutical partners. These solutions include studies on disease and drug mechanisms, discovery and evaluation of biomarkers and targets, patient stratification, multimodal AI prediction, optimization of clinical trial protocols, and precision medicine strategies. AliveX Biotech has served hundreds of clinical and research institutions as well as international large pharmaceutical companies. The company owns dozens of core technology patents and has obtained national high-tech enterprise certification, CAP certification from the American Society for Pathology, and ISO9001 certification.
